Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Icon, a global provider of outsourced development services to the pharma, biotechnology and medical device industries, is planning to expand its footprint in Asia-Pacific with the opening of a clinical development services office in Manila, Philippines.
Subscribe to our email newsletter
The announcement follows the recent expansion of Icon’s operations in Seoul, Korea and Icon Central Laboratories’ move to a larger laboratory facility in Singapore.
Reportedly, Icon has conducted a wide range of clinical studies across all therapeutic areas in Asia-Pacific, and has particular expertise in managing oncology, cardiovascular, CNS and metabolic disorder trials in the region.
Icon said that the current studies range from small local trials to pan-Asia-Pacific and large global programs and are supported by two fully-owned Icon central laboratories, strategically located in Singapore and Bangalore, India.
Peter Gray, CEO of Icon, said: “With over 800 employees in 14 Asia-Pac countries and 13 years of successful operations in the region, Asia-Pacific is a key market for Icon. Philippines’ large population, coupled with the country’s well-established network of hospitals, physicians and investigators has made it an attractive location for our clients, and one which we have supported for a number of years through home-based employees.
“Investing in local support and infrastructure through the office in Manila will ensure that we can support future client demand as they increasingly look to include Asia in their drug development programs.”